Download full-text PDF |
Source |
---|
Cureus
September 2024
Endocrinology and Diabetes, Lincoln Medical Centre, New York, USA.
J Med Case Rep
June 2024
National Hospital of Sri Lanka, Colombo, Sri Lanka.
Background: Insulin autoantibody syndrome (IAS), or Hirata disease, is caused by high concentrations of insulin autoantibodies, which result in spontaneous, mainly post-prandial, hypoglycemic episodes. We report a case of a previously healthy 67-year-old man presenting with recurrent fasting hypoglycemia culminating in a diagnosis of insulin autoimmune syndrome linked to omeprazole and probably spices, namely, coriander, and ginger.
Case Presentation: A previously healthy 67-year-old Sinhalese man presented with recurrent syncopal attacks for 3 months, which were found to be hypoglycemic episodes.
J Dent Educ
March 2024
Department of Oral and Maxillofacial Surgery, Henry M Goldman School of Dental Medicine of Boston University, Boston, Massachusetts, USA.
Purpose: The aims of this study were to estimate the type and frequency of different medical emergencies that occurred over the study period (twelve years) and discuss the lessons learned and the modifications made in the curriculum to better equip dental students and faculty in their management.
Materials And Methods: A retrospective study was conducted to evaluate all medical emergencies that needed activation of the response team at our school from 2008 to 2020.
Results: The emergency response system was activated 250 times during the 12-year period.
Ann Surg Oncol
March 2024
Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Background: Insulinomas are rare pancreatic neuroendocrine tumors for which the main curative treatment is surgical resection. Enucleation is preferred over pancreatoduodenectomy to minimize morbidity and function loss. Robotic-assisted surgery offers improved versatility and less blood loss than laparoscopic surgery for pancreatic enucleation.
View Article and Find Full Text PDFEur Heart J Cardiovasc Pharmacother
February 2024
Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Background And Aims: Syncope is a symptom that poses an important diagnostic and therapeutic challenge, and generates significant cost for the healthcare system. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have demonstrated beneficial cardiovascular effects, but their possible effects on incident syncope have not been fully investigated. This study compared the effects of SGLT2i and dipeptidyl peptidase-4 inhibitors (DPP4i) on new-onset syncope.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!